By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SynCo Bio Partners B.V. 

Paasheuvelweg 30

Amsterdam    1105 BJ  The Netherlands
Phone: Fax:



Company News
FDA Approves PaxVax, Inc. To Manufacture Vaxchora (Oral Cholera Vaccine) At SynCo Bio Partners B.V. 6/20/2016 6:17:50 AM
Advaxis, Inc. Engages SynCo Bio Partners B.V. For Manufacturing Of ADXS-HPV, Its Lead Cancer Immunotherapy Program 2/11/2014 9:16:44 AM
SynCo Bio Partners B.V. Expands the Class A Zone in its Aseptic Filling Facility 8/4/2011 10:40:59 AM
SynCo Bio Partners B.V. Signs New Manufacturing Agreements to Supply the US Market; Securing its Position as a Market Leader in Microbial Biopharmaceutical Contract Production 2/2/2010 11:24:48 AM
SynCo Bio Partners B.V. Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company 9/1/2009 11:41:43 AM
SynCo Bio Partners B.V. to Manufacture Versartis, Inc.'s Novel Drug for Type 2 Diabetes 8/17/2009 9:41:42 AM
SynCo Bio Partners B.V. Increases its Capacities by Expanding its Quality Team 7/20/2009 9:20:04 AM
SynCo Bio Partners B.V. Wins Best Contract Manufacturing Organisation 2009 ViE Award 4/30/2009 2:42:52 PM
SynCo Bio Partners B.V. Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 5/14/2008 7:34:43 AM
OncoMed Pharmaceuticals, Inc. Chooses SynCo Bio Partners B.V. to Fill and Finish its Lead Antibody 4/15/2008 9:13:55 AM